Neogenomics Inc (NASDAQ:NEO)

14.05
Delayed Data
As of Jun 22
 +0.13 / +0.93%
Today’s Change
7.08
Today|||52-Week Range
14.18
+58.58%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close13.92
Today’s open13.95
Day’s range13.87 - 14.18
Volume1,016,511
Average volume (3 months)413,152
Market cap$889.2M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+64.10%
Earnings growth (this year)+36.26%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+5.95%
P/E ratioNM
Price/Sales2.72
Price/Book5.13

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+2.03+14.46%
ENZEnzo Biochem Inc-0.13-2.42%
KANGiKang Healthcare Gro...-0.13-0.63%
RDNTRadNet Inc-0.05-0.35%
Data as of 4:09pm ET, 06/22/2018

Financials

Next reporting dateJuly 24, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$258.6M
Annual profit (last year)-$846.0K
Net profit margin-0.33%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts